From the Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea (J-YP, JY, C-SK, TM, Y-KK), Department of Anesthesiology and Pain Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Republic of Korea (J-WB).
Eur J Anaesthesiol. 2024 Nov 1;41(11):821-830. doi: 10.1097/EJA.0000000000002050. Epub 2024 Aug 13.
Catheter-related bladder discomfort (CRBD) is problematic in patients with a urinary catheter. Transcutaneous electrical nerve stimulation (TENS) is a non-invasive analgesic modality used to relieve various types of pain.
We evaluated the effect of TENS on CRBD after transurethral resection of bladder tumours (TURBT).
A randomised controlled trial.
A large university tertiary hospital, from October 2022 to March 2023.
Patients requiring urinary catheterisation after TURBT.
In this randomised controlled trial, patients were randomly allocated to the TENS ( n = 56) or control ( n = 56) groups. CRBD manifests as a burning sensation with an urge to void or discomfort in the suprapubic area. Moderate to severe CRBD was defined as patients self-reporting CRBD symptoms with or without behavioural response, including attempts to remove the urinary catheter, intense verbal reactions, and flailing limbs. TENS was performed from the end of surgery to 1 h postoperatively.
The primary endpoint was considered moderate to severe CRBD immediately postoperatively. Secondary endpoints included moderate to severe CRBD at 1, 2 and 6 h postoperatively. Additionally, postoperative pain, patient satisfaction, and TENS-related adverse effects were evaluated.
Moderate to severe CRBD immediately postoperatively was significantly less frequent in the TENS group than in the control group: 10 (17.9%) vs. 34 (60.7%); P < 0.001; relative risk (95% CI) = 0.294 (0.161 to 0.536); absolute risk reduction = 0.43; number needed to treat = 2.3. Moderate to severe CRBD differed between the two groups at 1 h postoperatively: 1 (1.8%) vs. 16 (28.6%); P < 0.001; relative risk = 0.06 (95% CI 0.01 to 0.46); absolute risk reduction = 0.27; number needed to treat = 3.7. The TENS group exhibited a significantly lower score for postoperative pain at 1 h (1.8 ± 0.6 vs. 2.2 ± 0.4; P < 0.001, mean difference (95% CI) = 0.4 (0.2 to 0.6) and a higher score for patient satisfaction, 5.0 (4.0 to 6.0) vs. 3.0 (3.0 to 4.0); P < 0.001; median difference (95% CI) = 2.0 (1.0 to 2.0).
TENS reduced moderate to severe CRBD, decreased postoperative pain, and increased patient satisfaction after TURBT.
Clinical Research Information Service (KCT0007450).
导尿管相关性膀胱不适(CRBD)是留置导尿管患者的一个问题。经皮神经电刺激(TENS)是一种用于缓解各种类型疼痛的非侵入性镇痛方式。
我们评估 TENS 对经尿道膀胱肿瘤切除术(TURBT)后 CRBD 的影响。
随机对照试验。
2022 年 10 月至 2023 年 3 月期间的一家大型大学附属医院。
需要 TURBT 后留置导尿管的患者。
在这项随机对照试验中,患者被随机分配到 TENS(n=56)或对照组(n=56)。CRBD 的表现为有排尿冲动或耻骨上区不适的烧灼感。中度至重度 CRBD 定义为患者自述有 CRBD 症状,伴有或不伴有行为反应,包括试图拔出导尿管、强烈的言语反应和挥舞四肢。TENS 从手术结束开始,持续到术后 1 小时。
主要终点是术后即刻的中重度 CRBD。次要终点包括术后 1、2 和 6 小时的中重度 CRBD。此外,还评估了术后疼痛、患者满意度和 TENS 相关不良反应。
与对照组相比,TENS 组术后即刻中重度 CRBD 显著减少:10(17.9%)vs. 34(60.7%);P<0.001;相对风险(95%CI)=0.294(0.161 至 0.536);绝对风险降低=0.43;需要治疗的人数=2.3。两组在术后 1 小时时中重度 CRBD 存在差异:1(1.8%)vs. 16(28.6%);P<0.001;相对风险=0.06(95%CI 0.01 至 0.46);绝对风险降低=0.27;需要治疗的人数=3.7。TENS 组术后 1 小时的疼痛评分明显较低(1.8±0.6 分 vs. 2.2±0.4 分;P<0.001,平均差异(95%CI)=0.4(0.2 至 0.6),且患者满意度评分较高,5.0(4.0 至 6.0)分 vs. 3.0(3.0 至 4.0)分;P<0.001;中位数差异(95%CI)=2.0(1.0 至 2.0)。
TENS 降低了 TURBT 后中重度 CRBD,减轻了术后疼痛,提高了患者满意度。
临床研究信息服务(KCT0007450)。